Opening a new chapter in family-building: What the IVF cost shift means for you
- ACRC Global
- 19 hours ago
- 3 min read
There’s a shift happening in the fertility landscape—one that could make your dream of family more accessible. According to ABC News, the U.S. federal government has struck a deal with pharmaceutical company EMD Serono to reduce the cost of key fertility medications, including those used in in-vitro fertilization (IVF). ABC News
For those exploring paths like surrogacy, egg-freezing, or fertility preservation, this announcement signals hope: fewer financial hurdles, more possibilities. At ACRC Global, we believe every family’s story deserves a chance—and every potential surrogate, egg donor or intended parent deserves clarity.
What’s changing—and why it matters
Here are some of the takeaway points from the ABC News article:
The deal is designed to lower the cost of fertility drugs (such as those used in IVF cycles) for people purchasing directly through the administration’s initiative. ABC News
For millions of Americans who face fertility challenges—approximately 9% of men and 11% of women of reproductive age, according to U.S. CDC statistics—this cost reduction can be a game-changer. ABC News
Many fertility treatments (IVF, egg-freezing, fertility preservation for cancer treatment) rely heavily on these medications—so lowering their cost removes a significant barrier. ABC News
The cost of one IVF cycle in the U.S. can average around $12,000 (sometimes much more depending on location, multiple rounds, etc.). ABC News
The new drug pricing benefit is expected to begin in January 2026, when the “direct purchasing platform” goes live. ABC News
Why this matters for surrogacy and family-building with ACRC Global
At ACRC Global, our mission is to make parenthood possible—and that means helping you navigate all the moving parts: finding the right surrogate or egg donor, understanding medical procedures, handling logistics and emotional considerations, and making sure costs are transparent.
With the cost of fertility medications coming down, here’s how that can positively affect your journey:
More budget flexibility – Lower drug costs may let intended parents allocate resources to other aspects of the journey (medical care, legal services, psychological support).
Better accessibility for more people – If surrogacy or donor cycles become more affordable, then more hopeful parents can access these paths, and more surrogates can participate with fewer financial stressors.
Improved fertility preservation support – For women or men facing fertility risk (e.g., cancer treatment), cheaper medications may make preservation more viable; that strengthens the overall family-building ecosystem.
Encouraging more surrogate participation – Surrogates play a critical role in enabling family creation. If the journey is more financially and medically sustainable, then it becomes a more attractive, supported choice.
What you should consider next
If you’re an intended parent, a surrogate candidate, or exploring egg donation, here are some steps to make sense of this shift:
Reach out to our team to review your budget and financial plan. We can help incorporate the potential savings from reduced fertility drug costs into your equation. (Visit our Become a Surrogate page or Surrogacy Process for more.)
Understand the medical timeline: Even with medications being more affordable, the treatments themselves—egg retrieval, embryo creation, implantation, surrogacy transfer—still involve specialized medical care.
Review the legal, psychological, and logistical aspects of your journey. Cost is a big piece, but so are contracts, insurance, travel (if applicable), and support for everyone involved.
Stay informed about when and how the drug-cost reductions will roll out. According to the ABC News article, the new platform launches in January 2026. ABC News
Decide if surrogacy is your path—for hopeful parents, surrogates, or donors. If you’re a surrogate candidate: check our Surrogacy Requirements page to see if this might be right for you.
ACRC Global is here for you
If you’re ready to talk about your family-building options—whether that’s surrogacy, egg-donation, or fertility preservation—our team at ACRC Global would love to connect. We’re committed to providing personalized guidance, transparent information and caring support. Explore our Contact Us page to schedule a consultation.
Original article credit: “What Trump’s IVF announcement means for women, families,” by Yi-Jin Yu, ABC News, October 17, 2025. Available at: https://abcnews.go.com/GMA/Wellness/trumps-ivf-announcement-means-women-families/story?id=126608910
Comments